nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—Cytochrome P450 2C8 Inhibitors—Pazopanib—kidney cancer	0.593	1	CiPCiCtD
Trimethoprim—ABCB1—kidney cancer	0.0766	1	CbGaD
Trimethoprim—TYMS—Capecitabine—kidney cancer	0.0756	0.309	CbGbCtD
Trimethoprim—TYMS—Gemcitabine—kidney cancer	0.0524	0.214	CbGbCtD
Trimethoprim—ABCB1—Temsirolimus—kidney cancer	0.0106	0.0434	CbGbCtD
Trimethoprim—CYP3A4—Everolimus—kidney cancer	0.0094	0.0385	CbGbCtD
Trimethoprim—CYP2C8—Pazopanib—kidney cancer	0.00823	0.0337	CbGbCtD
Trimethoprim—CYP3A4—Temsirolimus—kidney cancer	0.00635	0.026	CbGbCtD
Trimethoprim—CYP2C9—Capecitabine—kidney cancer	0.00599	0.0245	CbGbCtD
Trimethoprim—CYP2C8—Erlotinib—kidney cancer	0.00587	0.024	CbGbCtD
Trimethoprim—ABCB1—Pazopanib—kidney cancer	0.00557	0.0228	CbGbCtD
Trimethoprim—CYP2C8—Paclitaxel—kidney cancer	0.00537	0.022	CbGbCtD
Trimethoprim—ABCB1—Dactinomycin—kidney cancer	0.00509	0.0208	CbGbCtD
Trimethoprim—CYP2C8—Sorafenib—kidney cancer	0.00477	0.0195	CbGbCtD
Trimethoprim—ABCB1—Gemcitabine—kidney cancer	0.00403	0.0165	CbGbCtD
Trimethoprim—ABCB1—Erlotinib—kidney cancer	0.00397	0.0163	CbGbCtD
Trimethoprim—CYP2C9—Paclitaxel—kidney cancer	0.00375	0.0153	CbGbCtD
Trimethoprim—ABCB1—Paclitaxel—kidney cancer	0.00364	0.0149	CbGbCtD
Trimethoprim—CYP3A4—Pazopanib—kidney cancer	0.00334	0.0136	CbGbCtD
Trimethoprim—CYP2C9—Sorafenib—kidney cancer	0.00333	0.0136	CbGbCtD
Trimethoprim—ABCB1—Sorafenib—kidney cancer	0.00323	0.0132	CbGbCtD
Trimethoprim—ABCB1—Vinblastine—kidney cancer	0.00319	0.0131	CbGbCtD
Trimethoprim—ABCB1—Vincristine—kidney cancer	0.00314	0.0128	CbGbCtD
Trimethoprim—ABCB1—Sunitinib—kidney cancer	0.00262	0.0107	CbGbCtD
Trimethoprim—CYP3A4—Erlotinib—kidney cancer	0.00238	0.00974	CbGbCtD
Trimethoprim—CYP3A4—Paclitaxel—kidney cancer	0.00218	0.00892	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—kidney cancer	0.00196	0.00802	CbGbCtD
Trimethoprim—CYP3A4—Sorafenib—kidney cancer	0.00194	0.00792	CbGbCtD
Trimethoprim—CYP3A4—Vinblastine—kidney cancer	0.00191	0.00782	CbGbCtD
Trimethoprim—CYP3A4—Vincristine—kidney cancer	0.00188	0.00769	CbGbCtD
Trimethoprim—CYP3A4—Sunitinib—kidney cancer	0.00157	0.00642	CbGbCtD
Trimethoprim—CYP3A4—Doxorubicin—kidney cancer	0.00117	0.00481	CbGbCtD
Trimethoprim—CYP2C9—urine—kidney cancer	0.000842	0.122	CbGeAlD
Trimethoprim—CYP3A4—urine—kidney cancer	0.000642	0.0932	CbGeAlD
Trimethoprim—TYMS—nephron tubule—kidney cancer	0.000519	0.0753	CbGeAlD
Trimethoprim—DHFR—nephron tubule—kidney cancer	0.000514	0.0746	CbGeAlD
Trimethoprim—DHFR—renal system—kidney cancer	0.000467	0.0678	CbGeAlD
Trimethoprim—DHFR—kidney—kidney cancer	0.000452	0.0656	CbGeAlD
Trimethoprim—TYMS—cortex of kidney—kidney cancer	0.000444	0.0645	CbGeAlD
Trimethoprim—DHFR—cortex of kidney—kidney cancer	0.00044	0.0638	CbGeAlD
Trimethoprim—TYMS—gonad—kidney cancer	0.000423	0.0614	CbGeAlD
Trimethoprim—DHFR—gonad—kidney cancer	0.000419	0.0608	CbGeAlD
Trimethoprim—DHFR—cardiac atrium—kidney cancer	0.000418	0.0607	CbGeAlD
Trimethoprim—TYMS—Docetaxel—Paclitaxel—kidney cancer	0.000418	0.27	CbGdCrCtD
Trimethoprim—CYP2C8—renal system—kidney cancer	0.000232	0.0337	CbGeAlD
Trimethoprim—CYP2C8—kidney—kidney cancer	0.000224	0.0325	CbGeAlD
Trimethoprim—TYMS—Sirolimus—Everolimus—kidney cancer	0.000201	0.13	CbGdCrCtD
Trimethoprim—TYMS—Sirolimus—Temsirolimus—kidney cancer	0.000201	0.13	CbGdCrCtD
Trimethoprim—TYMS—Gefitinib—Erlotinib—kidney cancer	0.0002	0.129	CbGdCrCtD
Trimethoprim—CYP3A4—renal system—kidney cancer	0.000157	0.0228	CbGeAlD
Trimethoprim—CYP3A4—kidney—kidney cancer	0.000152	0.022	CbGeAlD
Trimethoprim—TYMS—Vinorelbine—Vinblastine—kidney cancer	0.000134	0.0866	CbGdCrCtD
Trimethoprim—TYMS—Vinorelbine—Vincristine—kidney cancer	0.000134	0.0866	CbGdCrCtD
Trimethoprim—ABCB1—nephron tubule—kidney cancer	0.000122	0.0178	CbGeAlD
Trimethoprim—TYMS—Vincristine—Vinblastine—kidney cancer	0.000115	0.074	CbGdCrCtD
Trimethoprim—ABCB1—renal system—kidney cancer	0.000111	0.0161	CbGeAlD
Trimethoprim—ABCB1—kidney—kidney cancer	0.000107	0.0156	CbGeAlD
Trimethoprim—ABCB1—cortex of kidney—kidney cancer	0.000105	0.0152	CbGeAlD
Trimethoprim—ABCB1—gonad—kidney cancer	9.97e-05	0.0145	CbGeAlD
Trimethoprim—TYMS—Vinblastine—Vincristine—kidney cancer	9.22e-05	0.0595	CbGdCrCtD
Trimethoprim—Epistaxis—Capecitabine—kidney cancer	5.6e-05	0.000901	CcSEcCtD
Trimethoprim—Vascular purpura—Doxorubicin—kidney cancer	5.55e-05	0.000893	CcSEcCtD
Trimethoprim—Agranulocytosis—Capecitabine—kidney cancer	5.54e-05	0.000891	CcSEcCtD
Trimethoprim—Anorexia—Vincristine—kidney cancer	5.54e-05	0.00089	CcSEcCtD
Trimethoprim—Anaphylactic shock—Gemcitabine—kidney cancer	5.51e-05	0.000886	CcSEcCtD
Trimethoprim—Dizziness—Vinblastine—kidney cancer	5.46e-05	0.000878	CcSEcCtD
Trimethoprim—Dizziness—Everolimus—kidney cancer	5.44e-05	0.000874	CcSEcCtD
Trimethoprim—Abdominal pain—Sunitinib—kidney cancer	5.43e-05	0.000873	CcSEcCtD
Trimethoprim—Body temperature increased—Sunitinib—kidney cancer	5.43e-05	0.000873	CcSEcCtD
Trimethoprim—Diarrhoea—Erlotinib—kidney cancer	5.43e-05	0.000873	CcSEcCtD
Trimethoprim—Nervous system disorder—Gemcitabine—kidney cancer	5.41e-05	0.000869	CcSEcCtD
Trimethoprim—TYMS—Azacitidine—Gemcitabine—kidney cancer	5.4e-05	0.0349	CbGdCrCtD
Trimethoprim—Thrombocytopenia—Gemcitabine—kidney cancer	5.4e-05	0.000868	CcSEcCtD
Trimethoprim—Feeling abnormal—Dactinomycin—kidney cancer	5.36e-05	0.000862	CcSEcCtD
Trimethoprim—Skin disorder—Gemcitabine—kidney cancer	5.36e-05	0.000861	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Dactinomycin—kidney cancer	5.32e-05	0.000855	CcSEcCtD
Trimethoprim—Tremor—Paclitaxel—kidney cancer	5.3e-05	0.000852	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Vincristine—kidney cancer	5.3e-05	0.000851	CcSEcCtD
Trimethoprim—Urinary tract disorder—Capecitabine—kidney cancer	5.27e-05	0.000846	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Doxorubicin—kidney cancer	5.27e-05	0.000846	CcSEcCtD
Trimethoprim—Hypersensitivity—Sorafenib—kidney cancer	5.26e-05	0.000846	CcSEcCtD
Trimethoprim—Insomnia—Vincristine—kidney cancer	5.26e-05	0.000845	CcSEcCtD
Trimethoprim—Anorexia—Gemcitabine—kidney cancer	5.26e-05	0.000845	CcSEcCtD
Trimethoprim—Vomiting—Vinblastine—kidney cancer	5.25e-05	0.000844	CcSEcCtD
Trimethoprim—Dizziness—Erlotinib—kidney cancer	5.25e-05	0.000844	CcSEcCtD
Trimethoprim—Connective tissue disorder—Capecitabine—kidney cancer	5.24e-05	0.000842	CcSEcCtD
Trimethoprim—Vomiting—Everolimus—kidney cancer	5.23e-05	0.000841	CcSEcCtD
Trimethoprim—Urethral disorder—Capecitabine—kidney cancer	5.23e-05	0.00084	CcSEcCtD
Trimethoprim—Renal impairment—Doxorubicin—kidney cancer	5.22e-05	0.000839	CcSEcCtD
Trimethoprim—Dermatitis bullous—Doxorubicin—kidney cancer	5.2e-05	0.000836	CcSEcCtD
Trimethoprim—Agitation—Paclitaxel—kidney cancer	5.2e-05	0.000835	CcSEcCtD
Trimethoprim—Rash—Everolimus—kidney cancer	5.19e-05	0.000834	CcSEcCtD
Trimethoprim—Dermatitis—Everolimus—kidney cancer	5.18e-05	0.000833	CcSEcCtD
Trimethoprim—Headache—Vinblastine—kidney cancer	5.17e-05	0.000832	CcSEcCtD
Trimethoprim—Angioedema—Paclitaxel—kidney cancer	5.17e-05	0.000831	CcSEcCtD
Trimethoprim—Purpura—Doxorubicin—kidney cancer	5.16e-05	0.000829	CcSEcCtD
Trimethoprim—Headache—Everolimus—kidney cancer	5.15e-05	0.000828	CcSEcCtD
Trimethoprim—Abdominal pain—Dactinomycin—kidney cancer	5.14e-05	0.000827	CcSEcCtD
Trimethoprim—Body temperature increased—Dactinomycin—kidney cancer	5.14e-05	0.000827	CcSEcCtD
Trimethoprim—Hypoglycaemia—Doxorubicin—kidney cancer	5.09e-05	0.000818	CcSEcCtD
Trimethoprim—Vertigo—Paclitaxel—kidney cancer	5.08e-05	0.000817	CcSEcCtD
Trimethoprim—Syncope—Paclitaxel—kidney cancer	5.07e-05	0.000815	CcSEcCtD
Trimethoprim—Lethargy—Doxorubicin—kidney cancer	5.07e-05	0.000815	CcSEcCtD
Trimethoprim—Leukopenia—Paclitaxel—kidney cancer	5.06e-05	0.000814	CcSEcCtD
Trimethoprim—Hypersensitivity—Sunitinib—kidney cancer	5.06e-05	0.000814	CcSEcCtD
Trimethoprim—Decreased appetite—Vincristine—kidney cancer	5.05e-05	0.000812	CcSEcCtD
Trimethoprim—Pruritus—Sorafenib—kidney cancer	5.05e-05	0.000812	CcSEcCtD
Trimethoprim—Vomiting—Erlotinib—kidney cancer	5.05e-05	0.000811	CcSEcCtD
Trimethoprim—Erythema multiforme—Capecitabine—kidney cancer	5.04e-05	0.00081	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Gemcitabine—kidney cancer	5.02e-05	0.000807	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Vincristine—kidney cancer	5.02e-05	0.000807	CcSEcCtD
Trimethoprim—Rash—Erlotinib—kidney cancer	5.01e-05	0.000804	CcSEcCtD
Trimethoprim—Dermatitis—Erlotinib—kidney cancer	5e-05	0.000804	CcSEcCtD
Trimethoprim—Hyponatraemia—Doxorubicin—kidney cancer	4.99e-05	0.000802	CcSEcCtD
Trimethoprim—Insomnia—Gemcitabine—kidney cancer	4.99e-05	0.000802	CcSEcCtD
Trimethoprim—Eye disorder—Capecitabine—kidney cancer	4.98e-05	0.000801	CcSEcCtD
Trimethoprim—Headache—Erlotinib—kidney cancer	4.97e-05	0.000799	CcSEcCtD
Trimethoprim—Tinnitus—Capecitabine—kidney cancer	4.97e-05	0.000799	CcSEcCtD
Trimethoprim—Loss of consciousness—Paclitaxel—kidney cancer	4.97e-05	0.000799	CcSEcCtD
Trimethoprim—Constipation—Vincristine—kidney cancer	4.97e-05	0.000799	CcSEcCtD
Trimethoprim—Cough—Paclitaxel—kidney cancer	4.94e-05	0.000793	CcSEcCtD
Trimethoprim—Dyspnoea—Gemcitabine—kidney cancer	4.92e-05	0.00079	CcSEcCtD
Trimethoprim—Nausea—Vinblastine—kidney cancer	4.91e-05	0.000788	CcSEcCtD
Trimethoprim—Convulsion—Paclitaxel—kidney cancer	4.9e-05	0.000788	CcSEcCtD
Trimethoprim—Nausea—Everolimus—kidney cancer	4.89e-05	0.000785	CcSEcCtD
Trimethoprim—Diarrhoea—Sorafenib—kidney cancer	4.89e-05	0.000785	CcSEcCtD
Trimethoprim—Pruritus—Sunitinib—kidney cancer	4.86e-05	0.000781	CcSEcCtD
Trimethoprim—Immune system disorder—Capecitabine—kidney cancer	4.82e-05	0.000774	CcSEcCtD
Trimethoprim—Myalgia—Paclitaxel—kidney cancer	4.82e-05	0.000774	CcSEcCtD
Trimethoprim—Arthralgia—Paclitaxel—kidney cancer	4.82e-05	0.000774	CcSEcCtD
Trimethoprim—Mediastinal disorder—Capecitabine—kidney cancer	4.81e-05	0.000772	CcSEcCtD
Trimethoprim—Anxiety—Paclitaxel—kidney cancer	4.8e-05	0.000771	CcSEcCtD
Trimethoprim—Decreased appetite—Gemcitabine—kidney cancer	4.79e-05	0.00077	CcSEcCtD
Trimethoprim—Hypersensitivity—Dactinomycin—kidney cancer	4.79e-05	0.00077	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	4.78e-05	0.000769	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Gemcitabine—kidney cancer	4.76e-05	0.000765	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Vincristine—kidney cancer	4.75e-05	0.000764	CcSEcCtD
Trimethoprim—Dizziness—Sorafenib—kidney cancer	4.72e-05	0.000759	CcSEcCtD
Trimethoprim—Constipation—Gemcitabine—kidney cancer	4.72e-05	0.000758	CcSEcCtD
Trimethoprim—Nausea—Erlotinib—kidney cancer	4.72e-05	0.000758	CcSEcCtD
Trimethoprim—Diarrhoea—Sunitinib—kidney cancer	4.7e-05	0.000756	CcSEcCtD
Trimethoprim—Ataxia—Doxorubicin—kidney cancer	4.67e-05	0.000751	CcSEcCtD
Trimethoprim—Mental disorder—Capecitabine—kidney cancer	4.67e-05	0.000751	CcSEcCtD
Trimethoprim—Confusional state—Paclitaxel—kidney cancer	4.66e-05	0.000748	CcSEcCtD
Trimethoprim—Erythema—Capecitabine—kidney cancer	4.64e-05	0.000746	CcSEcCtD
Trimethoprim—Malnutrition—Capecitabine—kidney cancer	4.64e-05	0.000746	CcSEcCtD
Trimethoprim—Anaphylactic shock—Paclitaxel—kidney cancer	4.62e-05	0.000742	CcSEcCtD
Trimethoprim—Body temperature increased—Vincristine—kidney cancer	4.6e-05	0.000739	CcSEcCtD
Trimethoprim—Abdominal pain—Vincristine—kidney cancer	4.6e-05	0.000739	CcSEcCtD
Trimethoprim—Dizziness—Sunitinib—kidney cancer	4.54e-05	0.00073	CcSEcCtD
Trimethoprim—Feeling abnormal—Gemcitabine—kidney cancer	4.54e-05	0.00073	CcSEcCtD
Trimethoprim—Shock—Paclitaxel—kidney cancer	4.54e-05	0.00073	CcSEcCtD
Trimethoprim—Vomiting—Sorafenib—kidney cancer	4.54e-05	0.00073	CcSEcCtD
Trimethoprim—Nervous system disorder—Paclitaxel—kidney cancer	4.53e-05	0.000728	CcSEcCtD
Trimethoprim—Thrombocytopenia—Paclitaxel—kidney cancer	4.52e-05	0.000726	CcSEcCtD
Trimethoprim—Rash—Sorafenib—kidney cancer	4.5e-05	0.000724	CcSEcCtD
Trimethoprim—Dermatitis—Sorafenib—kidney cancer	4.5e-05	0.000723	CcSEcCtD
Trimethoprim—Skin disorder—Paclitaxel—kidney cancer	4.48e-05	0.000721	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.47e-05	0.000719	CcSEcCtD
Trimethoprim—Headache—Sorafenib—kidney cancer	4.47e-05	0.000719	CcSEcCtD
Trimethoprim—Diarrhoea—Dactinomycin—kidney cancer	4.45e-05	0.000715	CcSEcCtD
Trimethoprim—Anorexia—Paclitaxel—kidney cancer	4.4e-05	0.000707	CcSEcCtD
Trimethoprim—Vomiting—Sunitinib—kidney cancer	4.37e-05	0.000702	CcSEcCtD
Trimethoprim—Body temperature increased—Gemcitabine—kidney cancer	4.36e-05	0.000701	CcSEcCtD
Trimethoprim—Tremor—Capecitabine—kidney cancer	4.35e-05	0.000699	CcSEcCtD
Trimethoprim—Rash—Sunitinib—kidney cancer	4.33e-05	0.000696	CcSEcCtD
Trimethoprim—Dermatitis—Sunitinib—kidney cancer	4.33e-05	0.000696	CcSEcCtD
Trimethoprim—Headache—Sunitinib—kidney cancer	4.31e-05	0.000692	CcSEcCtD
Trimethoprim—Hypersensitivity—Vincristine—kidney cancer	4.28e-05	0.000688	CcSEcCtD
Trimethoprim—Eosinophilia—Doxorubicin—kidney cancer	4.25e-05	0.000683	CcSEcCtD
Trimethoprim—Nausea—Sorafenib—kidney cancer	4.24e-05	0.000682	CcSEcCtD
Trimethoprim—Pancreatitis—Doxorubicin—kidney cancer	4.21e-05	0.000677	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.21e-05	0.000676	CcSEcCtD
Trimethoprim—Insomnia—Paclitaxel—kidney cancer	4.18e-05	0.000671	CcSEcCtD
Trimethoprim—Vertigo—Capecitabine—kidney cancer	4.17e-05	0.00067	CcSEcCtD
Trimethoprim—Syncope—Capecitabine—kidney cancer	4.16e-05	0.000669	CcSEcCtD
Trimethoprim—Leukopenia—Capecitabine—kidney cancer	4.16e-05	0.000668	CcSEcCtD
Trimethoprim—Vomiting—Dactinomycin—kidney cancer	4.14e-05	0.000665	CcSEcCtD
Trimethoprim—Dyspnoea—Paclitaxel—kidney cancer	4.12e-05	0.000662	CcSEcCtD
Trimethoprim—Rash—Dactinomycin—kidney cancer	4.1e-05	0.000659	CcSEcCtD
Trimethoprim—Nausea—Sunitinib—kidney cancer	4.08e-05	0.000656	CcSEcCtD
Trimethoprim—Loss of consciousness—Capecitabine—kidney cancer	4.08e-05	0.000656	CcSEcCtD
Trimethoprim—Pancytopenia—Doxorubicin—kidney cancer	4.08e-05	0.000655	CcSEcCtD
Trimethoprim—Dyspepsia—Paclitaxel—kidney cancer	4.06e-05	0.000653	CcSEcCtD
Trimethoprim—Cough—Capecitabine—kidney cancer	4.05e-05	0.000651	CcSEcCtD
Trimethoprim—Neutropenia—Doxorubicin—kidney cancer	4.02e-05	0.000645	CcSEcCtD
Trimethoprim—Decreased appetite—Paclitaxel—kidney cancer	4.01e-05	0.000645	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.99e-05	0.000641	CcSEcCtD
Trimethoprim—Diarrhoea—Vincristine—kidney cancer	3.98e-05	0.000639	CcSEcCtD
Trimethoprim—Myalgia—Capecitabine—kidney cancer	3.95e-05	0.000635	CcSEcCtD
Trimethoprim—Arthralgia—Capecitabine—kidney cancer	3.95e-05	0.000635	CcSEcCtD
Trimethoprim—Constipation—Paclitaxel—kidney cancer	3.95e-05	0.000635	CcSEcCtD
Trimethoprim—Anxiety—Capecitabine—kidney cancer	3.94e-05	0.000633	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.92e-05	0.000631	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Doxorubicin—kidney cancer	3.92e-05	0.00063	CcSEcCtD
Trimethoprim—Pruritus—Gemcitabine—kidney cancer	3.9e-05	0.000627	CcSEcCtD
Trimethoprim—Nausea—Dactinomycin—kidney cancer	3.86e-05	0.000621	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—kidney cancer	3.85e-05	0.000619	CcSEcCtD
Trimethoprim—Dizziness—Vincristine—kidney cancer	3.84e-05	0.000618	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—kidney cancer	3.83e-05	0.000615	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—kidney cancer	3.83e-05	0.000615	CcSEcCtD
Trimethoprim—Confusional state—Capecitabine—kidney cancer	3.82e-05	0.000614	CcSEcCtD
Trimethoprim—Feeling abnormal—Paclitaxel—kidney cancer	3.8e-05	0.000611	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.8e-05	0.00061	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Paclitaxel—kidney cancer	3.78e-05	0.000607	CcSEcCtD
Trimethoprim—Diarrhoea—Gemcitabine—kidney cancer	3.77e-05	0.000606	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—kidney cancer	3.76e-05	0.000605	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—kidney cancer	3.75e-05	0.000603	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—kidney cancer	3.73e-05	0.0006	CcSEcCtD
Trimethoprim—Shock—Capecitabine—kidney cancer	3.73e-05	0.000599	CcSEcCtD
Trimethoprim—Nervous system disorder—Capecitabine—kidney cancer	3.72e-05	0.000597	CcSEcCtD
Trimethoprim—Thrombocytopenia—Capecitabine—kidney cancer	3.71e-05	0.000596	CcSEcCtD
Trimethoprim—Vomiting—Vincristine—kidney cancer	3.7e-05	0.000594	CcSEcCtD
Trimethoprim—Skin disorder—Capecitabine—kidney cancer	3.68e-05	0.000591	CcSEcCtD
Trimethoprim—Urticaria—Paclitaxel—kidney cancer	3.67e-05	0.000589	CcSEcCtD
Trimethoprim—Rash—Vincristine—kidney cancer	3.66e-05	0.000589	CcSEcCtD
Trimethoprim—Dermatitis—Vincristine—kidney cancer	3.66e-05	0.000588	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—kidney cancer	3.65e-05	0.000587	CcSEcCtD
Trimethoprim—Body temperature increased—Paclitaxel—kidney cancer	3.65e-05	0.000587	CcSEcCtD
Trimethoprim—Abdominal pain—Paclitaxel—kidney cancer	3.65e-05	0.000587	CcSEcCtD
Trimethoprim—Headache—Vincristine—kidney cancer	3.64e-05	0.000585	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—kidney cancer	3.62e-05	0.000582	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—kidney cancer	3.61e-05	0.00058	CcSEcCtD
Trimethoprim—Anorexia—Capecitabine—kidney cancer	3.61e-05	0.00058	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—kidney cancer	3.57e-05	0.000574	CcSEcCtD
Trimethoprim—Vomiting—Gemcitabine—kidney cancer	3.51e-05	0.000563	CcSEcCtD
Trimethoprim—Rash—Gemcitabine—kidney cancer	3.48e-05	0.000559	CcSEcCtD
Trimethoprim—Dermatitis—Gemcitabine—kidney cancer	3.47e-05	0.000558	CcSEcCtD
Trimethoprim—Headache—Gemcitabine—kidney cancer	3.45e-05	0.000555	CcSEcCtD
Trimethoprim—Nausea—Vincristine—kidney cancer	3.45e-05	0.000555	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.45e-05	0.000555	CcSEcCtD
Trimethoprim—Insomnia—Capecitabine—kidney cancer	3.43e-05	0.000551	CcSEcCtD
Trimethoprim—Hypersensitivity—Paclitaxel—kidney cancer	3.4e-05	0.000547	CcSEcCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—kidney cancer	3.39e-05	0.000546	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—kidney cancer	3.38e-05	0.000543	CcSEcCtD
Trimethoprim—Dyspnoea—Capecitabine—kidney cancer	3.38e-05	0.000543	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—kidney cancer	3.37e-05	0.000542	CcSEcCtD
Trimethoprim—Dyspepsia—Capecitabine—kidney cancer	3.34e-05	0.000536	CcSEcCtD
Trimethoprim—Decreased appetite—Capecitabine—kidney cancer	3.29e-05	0.000529	CcSEcCtD
Trimethoprim—Nausea—Gemcitabine—kidney cancer	3.28e-05	0.000526	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Capecitabine—kidney cancer	3.27e-05	0.000526	CcSEcCtD
Trimethoprim—Pruritus—Paclitaxel—kidney cancer	3.27e-05	0.000525	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—kidney cancer	3.25e-05	0.000522	CcSEcCtD
Trimethoprim—Constipation—Capecitabine—kidney cancer	3.24e-05	0.000521	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—kidney cancer	3.21e-05	0.000516	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—kidney cancer	3.21e-05	0.000515	CcSEcCtD
Trimethoprim—Diarrhoea—Paclitaxel—kidney cancer	3.16e-05	0.000508	CcSEcCtD
Trimethoprim—Feeling abnormal—Capecitabine—kidney cancer	3.12e-05	0.000502	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—kidney cancer	3.1e-05	0.000499	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Capecitabine—kidney cancer	3.1e-05	0.000498	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—kidney cancer	3.1e-05	0.000498	CcSEcCtD
Trimethoprim—Dizziness—Paclitaxel—kidney cancer	3.05e-05	0.000491	CcSEcCtD
Trimethoprim—Mental disorder—Doxorubicin—kidney cancer	3.01e-05	0.000484	CcSEcCtD
Trimethoprim—Urticaria—Capecitabine—kidney cancer	3.01e-05	0.000484	CcSEcCtD
Trimethoprim—Abdominal pain—Capecitabine—kidney cancer	3e-05	0.000481	CcSEcCtD
Trimethoprim—Body temperature increased—Capecitabine—kidney cancer	3e-05	0.000481	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—kidney cancer	2.99e-05	0.000481	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—kidney cancer	2.99e-05	0.000481	CcSEcCtD
Trimethoprim—Vomiting—Paclitaxel—kidney cancer	2.94e-05	0.000472	CcSEcCtD
Trimethoprim—Rash—Paclitaxel—kidney cancer	2.91e-05	0.000468	CcSEcCtD
Trimethoprim—Dermatitis—Paclitaxel—kidney cancer	2.91e-05	0.000467	CcSEcCtD
Trimethoprim—Headache—Paclitaxel—kidney cancer	2.89e-05	0.000465	CcSEcCtD
Trimethoprim—Hypersensitivity—Capecitabine—kidney cancer	2.79e-05	0.000449	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—kidney cancer	2.75e-05	0.000442	CcSEcCtD
Trimethoprim—Nausea—Paclitaxel—kidney cancer	2.74e-05	0.000441	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—kidney cancer	2.69e-05	0.000432	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—kidney cancer	2.68e-05	0.000431	CcSEcCtD
Trimethoprim—Pruritus—Capecitabine—kidney cancer	2.68e-05	0.000431	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—kidney cancer	2.68e-05	0.00043	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—kidney cancer	2.63e-05	0.000423	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—kidney cancer	2.61e-05	0.00042	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—kidney cancer	2.59e-05	0.000417	CcSEcCtD
Trimethoprim—Diarrhoea—Capecitabine—kidney cancer	2.59e-05	0.000417	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—kidney cancer	2.55e-05	0.000409	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—kidney cancer	2.55e-05	0.000409	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—kidney cancer	2.54e-05	0.000408	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.53e-05	0.000407	CcSEcCtD
Trimethoprim—Dizziness—Capecitabine—kidney cancer	2.51e-05	0.000403	CcSEcCtD
Trimethoprim—Confusional state—Doxorubicin—kidney cancer	2.46e-05	0.000396	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—kidney cancer	2.44e-05	0.000393	CcSEcCtD
Trimethoprim—Vomiting—Capecitabine—kidney cancer	2.41e-05	0.000387	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—kidney cancer	2.4e-05	0.000386	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—kidney cancer	2.4e-05	0.000385	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—kidney cancer	2.39e-05	0.000384	CcSEcCtD
Trimethoprim—Rash—Capecitabine—kidney cancer	2.39e-05	0.000384	CcSEcCtD
Trimethoprim—Dermatitis—Capecitabine—kidney cancer	2.39e-05	0.000384	CcSEcCtD
Trimethoprim—Headache—Capecitabine—kidney cancer	2.37e-05	0.000381	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—kidney cancer	2.37e-05	0.000381	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—kidney cancer	2.33e-05	0.000374	CcSEcCtD
Trimethoprim—Nausea—Capecitabine—kidney cancer	2.25e-05	0.000362	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.23e-05	0.000358	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—kidney cancer	2.21e-05	0.000355	CcSEcCtD
Trimethoprim—Dyspnoea—Doxorubicin—kidney cancer	2.18e-05	0.00035	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—kidney cancer	2.15e-05	0.000346	CcSEcCtD
Trimethoprim—Decreased appetite—Doxorubicin—kidney cancer	2.12e-05	0.000341	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.11e-05	0.000339	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—kidney cancer	2.09e-05	0.000336	CcSEcCtD
Trimethoprim—Feeling abnormal—Doxorubicin—kidney cancer	2.01e-05	0.000323	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—kidney cancer	2e-05	0.000321	CcSEcCtD
Trimethoprim—Urticaria—Doxorubicin—kidney cancer	1.94e-05	0.000312	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—kidney cancer	1.93e-05	0.00031	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—kidney cancer	1.93e-05	0.00031	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—kidney cancer	1.8e-05	0.000289	CcSEcCtD
Trimethoprim—Pruritus—Doxorubicin—kidney cancer	1.73e-05	0.000278	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—kidney cancer	1.67e-05	0.000269	CcSEcCtD
Trimethoprim—Dizziness—Doxorubicin—kidney cancer	1.61e-05	0.00026	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—kidney cancer	1.55e-05	0.00025	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—kidney cancer	1.54e-05	0.000247	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—kidney cancer	1.54e-05	0.000247	CcSEcCtD
Trimethoprim—Headache—Doxorubicin—kidney cancer	1.53e-05	0.000246	CcSEcCtD
Trimethoprim—Nausea—Doxorubicin—kidney cancer	1.45e-05	0.000233	CcSEcCtD
Trimethoprim—DHFR—Metabolism—BCHE—kidney cancer	1.15e-05	0.000751	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—SLC5A5—kidney cancer	1.13e-05	0.000742	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—CCND1—kidney cancer	1.11e-05	0.000728	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ACY1—kidney cancer	1.1e-05	0.000721	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—SLC2A1—kidney cancer	1.09e-05	0.000716	CbGpPWpGaD
Trimethoprim—ABCB1—Allograft Rejection—VEGFA—kidney cancer	1.09e-05	0.000715	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SCARB1—kidney cancer	1.09e-05	0.000712	CbGpPWpGaD
Trimethoprim—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.08e-05	0.000709	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.08e-05	0.000706	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS1—kidney cancer	1.08e-05	0.000705	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PDHB—kidney cancer	1.07e-05	0.000704	CbGpPWpGaD
Trimethoprim—CYP2C8—Biological oxidations—POMC—kidney cancer	1.07e-05	0.000701	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN2B—kidney cancer	1.06e-05	0.000691	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PSMD7—kidney cancer	1.06e-05	0.000691	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CDKN1B—kidney cancer	1.04e-05	0.000682	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ACY1—kidney cancer	1.03e-05	0.000673	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN2A—kidney cancer	1.03e-05	0.000672	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.02e-05	0.000666	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CCBL1—kidney cancer	1.01e-05	0.000661	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—BCHE—kidney cancer	1e-05	0.000655	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—CCND1—kidney cancer	9.94e-06	0.000651	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SLC5A5—kidney cancer	9.88e-06	0.000647	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—CCND1—kidney cancer	9.7e-06	0.000635	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—SLC2A1—kidney cancer	9.54e-06	0.000625	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PDHB—kidney cancer	9.36e-06	0.000613	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MAPK3—kidney cancer	9.17e-06	0.0006	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	9.13e-06	0.000598	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTP1—kidney cancer	9.12e-06	0.000597	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CDKN1B—kidney cancer	9.09e-06	0.000595	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	9.01e-06	0.00059	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MYC—kidney cancer	8.92e-06	0.000584	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTP1—kidney cancer	8.85e-06	0.00058	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CCBL1—kidney cancer	8.8e-06	0.000576	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	8.77e-06	0.000574	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GLIPR1—kidney cancer	8.76e-06	0.000573	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PPAT—kidney cancer	8.76e-06	0.000573	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PDHB—kidney cancer	8.74e-06	0.000573	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	8.73e-06	0.000572	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle, Mitotic—MAPK1—kidney cancer	8.72e-06	0.000571	CbGpPWpGaD
Trimethoprim—CYP2C9—Biological oxidations—POMC—kidney cancer	8.71e-06	0.000571	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—CCND1—kidney cancer	8.67e-06	0.000568	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	8.64e-06	0.000566	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—ABCB1—kidney cancer	8.63e-06	0.000566	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	8.56e-06	0.000561	CbGpPWpGaD
Trimethoprim—DHFR—Disease—HIF1A—kidney cancer	8.44e-06	0.000553	CbGpPWpGaD
Trimethoprim—DHFR—Disease—TSC2—kidney cancer	8.42e-06	0.000551	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—GSTM1—kidney cancer	8.38e-06	0.000549	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CCBL1—kidney cancer	8.22e-06	0.000538	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MAPK3—kidney cancer	8.2e-06	0.000537	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—FH—kidney cancer	8.14e-06	0.000533	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—APRT—kidney cancer	8.14e-06	0.000533	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—GSTM1—kidney cancer	8.13e-06	0.000533	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	8.02e-06	0.000525	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MAPK3—kidney cancer	8e-06	0.000524	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MYC—kidney cancer	7.97e-06	0.000522	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTP1—kidney cancer	7.96e-06	0.000521	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	7.96e-06	0.000521	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—CYP1A1—kidney cancer	7.95e-06	0.000521	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—MAPK1—kidney cancer	7.8e-06	0.000511	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MYC—kidney cancer	7.78e-06	0.00051	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	7.71e-06	0.000505	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GPC3—kidney cancer	7.65e-06	0.000501	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PPAT—kidney cancer	7.63e-06	0.0005	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GLIPR1—kidney cancer	7.63e-06	0.0005	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle, Mitotic—MAPK1—kidney cancer	7.61e-06	0.000499	CbGpPWpGaD
Trimethoprim—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	7.6e-06	0.000498	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—ABCB1—kidney cancer	7.53e-06	0.000494	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA2—kidney cancer	7.44e-06	0.000488	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.43e-06	0.000487	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KIT—kidney cancer	7.43e-06	0.000487	CbGpPWpGaD
Trimethoprim—DHFR—Disease—APC—kidney cancer	7.43e-06	0.000487	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—GSTM1—kidney cancer	7.31e-06	0.000479	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALAD—kidney cancer	7.25e-06	0.000475	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MAPK3—kidney cancer	7.15e-06	0.000468	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GLIPR1—kidney cancer	7.13e-06	0.000467	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PPAT—kidney cancer	7.13e-06	0.000467	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—APRT—kidney cancer	7.09e-06	0.000464	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—FH—kidney cancer	7.09e-06	0.000464	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ST3GAL2—kidney cancer	7.08e-06	0.000464	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	7.07e-06	0.000463	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	7.04e-06	0.000461	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	7e-06	0.000458	CbGpPWpGaD
Trimethoprim—DHFR—Disease—BRAF—kidney cancer	6.99e-06	0.000458	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.96e-06	0.000456	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MYC—kidney cancer	6.96e-06	0.000456	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—CYP1A1—kidney cancer	6.93e-06	0.000454	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ALDH1A1—kidney cancer	6.92e-06	0.000453	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	6.84e-06	0.000448	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—MAPK1—kidney cancer	6.8e-06	0.000446	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACY1—kidney cancer	6.78e-06	0.000444	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GPC3—kidney cancer	6.67e-06	0.000437	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC5A3—kidney cancer	6.64e-06	0.000435	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PGK1—kidney cancer	6.64e-06	0.000435	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—FH—kidney cancer	6.62e-06	0.000434	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—APRT—kidney cancer	6.62e-06	0.000434	CbGpPWpGaD
Trimethoprim—DHFR—Cell Cycle—TP53—kidney cancer	6.55e-06	0.000429	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	6.51e-06	0.000426	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—LDHB—kidney cancer	6.51e-06	0.000426	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA2—kidney cancer	6.49e-06	0.000425	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	6.48e-06	0.000424	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.47e-06	0.000424	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALAD—kidney cancer	6.32e-06	0.000414	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	6.29e-06	0.000412	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GPC3—kidney cancer	6.23e-06	0.000408	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	6.18e-06	0.000405	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ST3GAL2—kidney cancer	6.17e-06	0.000404	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	6.17e-06	0.000404	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	6.12e-06	0.000401	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA2—kidney cancer	6.06e-06	0.000397	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ALDH1A1—kidney cancer	6.03e-06	0.000395	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	5.97e-06	0.000391	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—POMC—kidney cancer	5.92e-06	0.000388	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALAD—kidney cancer	5.9e-06	0.000387	CbGpPWpGaD
Trimethoprim—DHFR—Disease—RAF1—kidney cancer	5.83e-06	0.000382	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PGK1—kidney cancer	5.78e-06	0.000379	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC5A3—kidney cancer	5.78e-06	0.000379	CbGpPWpGaD
Trimethoprim—DHFR—Disease—ERBB2—kidney cancer	5.77e-06	0.000378	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PDHB—kidney cancer	5.76e-06	0.000378	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ST3GAL2—kidney cancer	5.76e-06	0.000377	CbGpPWpGaD
Trimethoprim—CYP3A4—Biological oxidations—POMC—kidney cancer	5.75e-06	0.000376	CbGpPWpGaD
Trimethoprim—TYMS—Cell Cycle—TP53—kidney cancer	5.71e-06	0.000374	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MTOR—kidney cancer	5.69e-06	0.000373	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CD4—kidney cancer	5.68e-06	0.000372	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—LDHB—kidney cancer	5.67e-06	0.000371	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTGS2—kidney cancer	5.64e-06	0.00037	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CA9—kidney cancer	5.64e-06	0.00037	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ALDH1A1—kidney cancer	5.63e-06	0.000369	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.51e-06	0.000361	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CCBL1—kidney cancer	5.42e-06	0.000355	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PGK1—kidney cancer	5.4e-06	0.000354	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.4e-06	0.000354	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	5.39e-06	0.000353	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CDKN1B—kidney cancer	5.34e-06	0.00035	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—LDHB—kidney cancer	5.3e-06	0.000347	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—POMC—kidney cancer	5.17e-06	0.000339	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	5.1e-06	0.000334	CbGpPWpGaD
Trimethoprim—DHFR—Disease—CTNNB1—kidney cancer	5.05e-06	0.000331	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	4.96e-06	0.000325	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PTEN—kidney cancer	4.92e-06	0.000322	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CA9—kidney cancer	4.92e-06	0.000322	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	4.85e-06	0.000318	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CRABP1—kidney cancer	4.8e-06	0.000314	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTGS2—kidney cancer	4.73e-06	0.00031	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.7e-06	0.000308	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PPAT—kidney cancer	4.7e-06	0.000308	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CA9—kidney cancer	4.59e-06	0.000301	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	4.58e-06	0.0003	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.49e-06	0.000294	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ITPR2—kidney cancer	4.46e-06	0.000292	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—FH—kidney cancer	4.37e-06	0.000286	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—APRT—kidney cancer	4.37e-06	0.000286	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.21e-06	0.000276	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK3—kidney cancer	4.2e-06	0.000275	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CRABP1—kidney cancer	4.18e-06	0.000274	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTGS2—kidney cancer	4.12e-06	0.00027	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PTEN—kidney cancer	4.12e-06	0.00027	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.11e-06	0.000269	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GPC3—kidney cancer	4.11e-06	0.000269	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MYC—kidney cancer	4.09e-06	0.000268	CbGpPWpGaD
Trimethoprim—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.07e-06	0.000267	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTT1—kidney cancer	4.07e-06	0.000266	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ACHE—kidney cancer	4.07e-06	0.000266	CbGpPWpGaD
Trimethoprim—DHFR—Disease—MAPK1—kidney cancer	4e-06	0.000262	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA2—kidney cancer	4e-06	0.000262	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CRABP1—kidney cancer	3.9e-06	0.000256	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALAD—kidney cancer	3.89e-06	0.000255	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ITPR2—kidney cancer	3.89e-06	0.000255	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SCARB1—kidney cancer	3.85e-06	0.000252	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS1—kidney cancer	3.81e-06	0.00025	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.8e-06	0.000249	CbGpPWpGaD
Trimethoprim—DHFR—Disease—KRAS—kidney cancer	3.78e-06	0.000248	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PSMD7—kidney cancer	3.74e-06	0.000245	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.71e-06	0.000243	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ITPR2—kidney cancer	3.63e-06	0.000238	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PTEN—kidney cancer	3.6e-06	0.000236	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.56e-06	0.000233	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PGK1—kidney cancer	3.56e-06	0.000233	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—ACHE—kidney cancer	3.54e-06	0.000232	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTT1—kidney cancer	3.54e-06	0.000232	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—BCHE—kidney cancer	3.54e-06	0.000232	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.5e-06	0.000229	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—LDHB—kidney cancer	3.49e-06	0.000229	CbGpPWpGaD
Trimethoprim—DHFR—Disease—PIK3CA—kidney cancer	3.47e-06	0.000227	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.38e-06	0.000221	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SCARB1—kidney cancer	3.35e-06	0.00022	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.35e-06	0.000219	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS1—kidney cancer	3.32e-06	0.000217	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ACHE—kidney cancer	3.31e-06	0.000217	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTT1—kidney cancer	3.31e-06	0.000217	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.28e-06	0.000215	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PSMD7—kidney cancer	3.26e-06	0.000213	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SCARB1—kidney cancer	3.13e-06	0.000205	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS1—kidney cancer	3.1e-06	0.000203	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—BCHE—kidney cancer	3.09e-06	0.000202	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC5A5—kidney cancer	3.05e-06	0.0002	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PSMD7—kidney cancer	3.04e-06	0.000199	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CA9—kidney cancer	3.03e-06	0.000198	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—SLC2A1—kidney cancer	2.94e-06	0.000193	CbGpPWpGaD
Trimethoprim—DHFR—Metabolism—PIK3CA—kidney cancer	2.91e-06	0.00019	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—BCHE—kidney cancer	2.88e-06	0.000189	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.86e-06	0.000187	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.85e-06	0.000187	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTP1—kidney cancer	2.82e-06	0.000185	CbGpPWpGaD
Trimethoprim—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.81e-06	0.000184	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.75e-06	0.00018	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.67e-06	0.000175	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—ABCB1—kidney cancer	2.67e-06	0.000175	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—GSTM1—kidney cancer	2.59e-06	0.00017	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CRABP1—kidney cancer	2.57e-06	0.000169	CbGpPWpGaD
Trimethoprim—TYMS—Metabolism—PIK3CA—kidney cancer	2.54e-06	0.000166	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTP1—kidney cancer	2.46e-06	0.000161	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.46e-06	0.000161	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ITPR2—kidney cancer	2.39e-06	0.000157	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.33e-06	0.000152	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTP1—kidney cancer	2.29e-06	0.00015	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—GSTM1—kidney cancer	2.26e-06	0.000148	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTT1—kidney cancer	2.18e-06	0.000143	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ACHE—kidney cancer	2.18e-06	0.000143	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—ABCB1—kidney cancer	2.17e-06	0.000142	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—CYP1A1—kidney cancer	2.14e-06	0.00014	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—GSTM1—kidney cancer	2.11e-06	0.000138	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SCARB1—kidney cancer	2.07e-06	0.000135	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS1—kidney cancer	2.05e-06	0.000134	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.02e-06	0.000132	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PSMD7—kidney cancer	2.01e-06	0.000131	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—CYP1A1—kidney cancer	2e-06	0.000131	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—BCHE—kidney cancer	1.9e-06	0.000125	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.88e-06	0.000123	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—POMC—kidney cancer	1.83e-06	0.00012	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.81e-06	0.000119	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.64e-06	0.000108	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—POMC—kidney cancer	1.6e-06	0.000104	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTP1—kidney cancer	1.51e-06	9.91e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—POMC—kidney cancer	1.49e-06	9.76e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTGS2—kidney cancer	1.46e-06	9.57e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—ABCB1—kidney cancer	1.43e-06	9.38e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—GSTM1—kidney cancer	1.39e-06	9.11e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.32e-06	8.63e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PTEN—kidney cancer	1.27e-06	8.34e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTGS2—kidney cancer	1.27e-06	8.33e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTGS2—kidney cancer	1.19e-06	7.79e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PTEN—kidney cancer	1.11e-06	7.27e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PTEN—kidney cancer	1.04e-06	6.79e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—POMC—kidney cancer	9.83e-07	6.44e-05	CbGpPWpGaD
Trimethoprim—CYP2C8—Metabolism—PIK3CA—kidney cancer	8.98e-07	5.89e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTGS2—kidney cancer	7.84e-07	5.13e-05	CbGpPWpGaD
Trimethoprim—ABCB1—Metabolism—PIK3CA—kidney cancer	7.83e-07	5.13e-05	CbGpPWpGaD
Trimethoprim—CYP2C9—Metabolism—PIK3CA—kidney cancer	7.31e-07	4.79e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PTEN—kidney cancer	6.84e-07	4.48e-05	CbGpPWpGaD
Trimethoprim—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.82e-07	3.16e-05	CbGpPWpGaD
